Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Gilead Sciences, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
GILD
Nasdaq
2834
https://www.gilead.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Gilead Sciences, Inc.
Gilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again
- Apr 26th, 2024 8:10 pm
Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
- Apr 26th, 2024 2:24 pm
Q1 2024 Gilead Sciences Inc Earnings Call
- Apr 26th, 2024 12:11 pm
FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
- Apr 26th, 2024 12:00 pm
Gilead Sciences Inc (GILD) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...
- Apr 26th, 2024 7:35 am
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript
- Apr 26th, 2024 1:45 am
Gilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say
- Apr 25th, 2024 10:00 pm
Gilead Beats Earnings Expectations After Rocky Quarter
- Apr 25th, 2024 9:49 pm
Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ...
- Apr 25th, 2024 9:41 pm
Gilead Sciences (GILD) Reports Q1 Loss, Tops Revenue Estimates
- Apr 25th, 2024 9:15 pm
Gilead posts quarterly loss on acquisition charge, revenue rises 5%
- Apr 25th, 2024 8:11 pm
Gilead Sciences Announces First Quarter 2024 Financial Results
- Apr 25th, 2024 8:02 pm
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
- Apr 24th, 2024 1:19 pm
Incyte (INCY) Earnings Expected to Grow: Should You Buy?
- Apr 23rd, 2024 2:01 pm
Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
- Apr 22nd, 2024 5:57 pm
Insights Into Gilead (GILD) Q1: Wall Street Projections for Key Metrics
- Apr 22nd, 2024 1:16 pm
Gilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know
- Apr 19th, 2024 9:50 pm
US FDA mandates label updates on CAR-T cancer therapies
- Apr 18th, 2024 10:33 pm
Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
- Apr 18th, 2024 10:00 pm
Gilead Sciences Publishes 2023 ESG Impact Report
- Apr 18th, 2024 5:45 pm
Scroll